New York Amends Shared Pharmacy Services Rules: Relief for Non-Resident and Centralized Pharmacies

On January 21, 2025, the New York State Board of Regents adopted amendments to 8 NYCRR § 63.6(b)(11), narrowing the scope of shared pharmacy services regulations that previously applied to both centralized prescription processing facilities and third-party service providers. The rule change exempts certain non-resident pharmacies and centralized operations from shared services registration requirements when they perform limited technical functions for New York-licensed pharmacies. For wholesale distributors serving these pharmacy networks, the amendment reduces regulatory friction in supply chain arrangements tied to multi-state prescription fulfillment infrastructure.

Background: Shared Pharmacy Services Under New York Law

New York regulates shared pharmacy services under 8 NYCRR § 63.6, which governs arrangements where pharmacy functions are outsourced to third parties or centralized within a corporate pharmacy network. The original framework, codified in 2018, required registration for any entity performing dispensing-related services on behalf of a New York pharmacy — including inventory management, order processing, drug utilization review, and prescription assembly conducted outside the state.

This created compliance complexity for centralized pharmacy operations serving multi-state retail or health system networks. Non-resident pharmacies licensed in other states but handling New York prescriptions were subject to dual oversight: home-state licensure plus New York shared services registration. The regulation applied broadly to both corporate-owned centralized facilities (e.g., CVS or Walgreens regional hubs) and contracted third-party service providers.

The New York State Board of Pharmacy proposed amendments in 2023 to distinguish between centralized prescription processing — where a pharmacy outsources technical steps to another licensed pharmacy within the same corporate structure — and true third-party shared services, where an independent entity performs pharmacy functions under contract. The Board of Regents formalized this distinction in the January 2025 rule adoption.

Key Provisions of the Amended Rule

The amended regulation redefines shared pharmacy services to exclude:

1. Centralized prescription processing performed by a non-resident pharmacy licensed under 8 NYCRR § 63.6(b)(11)(i) — If the non-resident pharmacy is part of the same corporate entity as the New York pharmacy it serves, and holds an active non-resident pharmacy license, it is exempt from separate shared services registration. The centralized facility must still comply with all applicable pharmacy practice standards in its home state.

1. Technical prescription preparation activities delegated to pharmacies holding equivalent licensure — Non-resident pharmacies performing order entry, label generation, and drug utilization review for New York pharmacies under corporate affiliation no longer trigger shared services obligations, provided the receiving pharmacy (in New York) retains final verification and dispensing authority.

1. Ongoing registration for independent third-party service providers — The exemption does not apply to entities that are not licensed pharmacies or that provide services outside a corporate-affiliate relationship. Contract pharmacy service providers (e.g., specialty pharmacy hubs contracted by health systems) remain subject to shared services registration under the existing framework.

The rule took effect immediately upon adoption. No grace period was specified for entities that previously registered under the broader interpretation — the Board's position is that these entities were never required to register if they met the amended criteria.

Operational Impact on Wholesale Drug Distributors

The amendment has direct implications for wholesale distributors supplying centralized pharmacy operations serving New York:

Simplified vendor qualification for multi-state pharmacy networks — Distributors no longer need to verify dual registration (non-resident pharmacy license + shared services registration) for centralized facilities within corporate pharmacy chains. A valid non-resident pharmacy license is sufficient for compliance documentation in vendor qualification audits.

Unchanged obligations for third-party specialty hubs — Wholesale distributors supplying independent specialty pharmacies or contract fulfillment centers must still confirm shared services registration if those entities process prescriptions for New York-licensed pharmacies. The exemption does not extend beyond corporate-affiliate relationships.

Cold chain supply considerations — For specialty and biologics distributors serving centralized pharmacy hubs, the regulatory change simplifies the compliance matrix but does not alter underlying storage and handling requirements under 21 CFR Part 205 or state pedigree laws. Distributors must still maintain chain-of-custody documentation and temperature monitoring regardless of the receiving pharmacy's registration status.

3PL contract language — Third-party logistics providers warehousing inventory for centralized pharmacies should review customer contracts to ensure regulatory representations align with the amended rule. If a 3PL contract requires the customer to maintain shared services registration as a condition of service, that clause may now be overbroad for corporate-owned centralized facilities. For comprehensive guidance on 3PL licensing obligations, see the pharmaceutical 3PL licensing requirements guide.

What ColdChainCheck Data Shows

ColdChainCheck tracks 1,275 wholesale drug distributors and 3PLs across 51 jurisdictions, including entities serving pharmacy networks with centralized prescription processing operations. Of the 127 entities in the directory with New York as a licensed state, 89 hold active wholesale drug distributor licenses — the regulatory pathway most relevant to facilities supplying centralized pharmacies exempt under the amended rule.

The average compliance score across all tracked entities is 51/100, placing the industry in the "Fair" tier. This reflects incomplete public data availability for certain compliance dimensions — notably state-level specialty designations and voluntary accreditations beyond NABP's core programs. Only 63 entities in the directory hold NABP accreditation (formerly VAWD), representing approximately 5% of the tracked population. For wholesale distributors serving multi-state pharmacy operations, the limited accreditation rate suggests most entities rely on baseline state licensure rather than enhanced verification standards.

The compliance score distribution shows 28 entities in the "Excellent" tier (76-100 points), 281 in "Good" (51-75), and 919 in "Fair" (26-50). The concentration in the Fair tier reflects the broader industry pattern: most distributors maintain active state licenses and FDA registration but lack supplementary compliance signals such as voluntary accreditations or documented quality certifications.

Practical Guidance for QA and Compliance Teams

For distributors supplying centralized pharmacy hubs:

• Verify non-resident pharmacy license status — Use the ColdChainCheck directory to confirm whether a centralized facility serving New York holds an active non-resident pharmacy license in New York. Filter by entity name and check the "State Licenses" field for NY pharmacy licensure. If the facility holds a valid non-resident license and operates under corporate affiliation, shared services registration is no longer required.
• Update vendor qualification checklists — Remove "New York shared services registration" as a required data point for corporate-owned centralized pharmacies. Retain the requirement for independent third-party service providers that are not licensed pharmacies themselves.
• Document the regulatory basis — In vendor files, reference 8 NYCRR § 63.6(b)(11) as amended January 21, 2025, to explain why shared services registration is not expected for qualifying entities. This preempts auditor questions during regulatory inspections.

For 3PLs warehousing inventory for pharmacy networks:

• Review customer compliance representations — If your contract requires the customer (centralized pharmacy) to maintain New York shared services registration, assess whether that clause applies under the amended rule. Corporate-affiliate centralized facilities are now exempt.

ColdChainCheck tracks state pharmacy board enforcement actions and regulatory changes affecting wholesale distributor compliance obligations. For guidance on multi-state pharmacy supply chain requirements, see the DSCSA compliance framework and state-specific licensure coverage in the directory.

Disclaimer: This article is informational only and does not constitute legal or regulatory advice. Entities should consult legal counsel and verify requirements directly with the New York State Board of Pharmacy and other relevant authorities.